Clinical trial
An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy…
NCT00408642 · Centre for the AIDS Programme of Research in South Africa, Other · Completed
Key facts
| NCT number | NCT00408642 |
|---|---|
| Title | An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART) |
| Official title | An Enhanced Adherence Support Programme for HAART |
| Acronym | eASP |
| Lead sponsor | Centre for the AIDS Programme of Research in South Africa, Other |
| Collaborators | Doris Duke Charitable Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | Enhanced adherence support, Standard adherence support |
| Enrollment | 297 |
| Start date | Aug 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Dec 7, 2006 |
| Last update posted | Feb 1, 2016 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: